Balance Sheet - Spyre Therapeutics, Inc. (SYRE)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 756.53 | 603.09 | 339.28 | 55.71 | 93.13 | 146.27 | 71.95 | 74.51 | 50.30 | 63.50 | 33.06 | 2.62 | 4.60 |
| Accounts receivable, net | 0.38 | 0.82 | 0.30 | 3.08 | 1.22 | 1.70 | |||||||
| Other current assets | 21.25 | 5.39 | 2.25 | 6.17 | 4.95 | 3.52 | 2.56 | 2.16 | 1.61 | 1.71 | 3.53 | 0.11 | |
| Total current assets | 777.78 | 608.47 | 341.53 | 62.26 | 98.89 | 149.79 | 74.51 | 76.67 | 54.99 | 66.42 | 38.29 | 2.73 | 4.60 |
| Total non-current assets | 0.00 | 0.01 | 0.33 | 8.89 | 11.04 | 11.83 | 8.68 | 1.07 | 1.09 | 0.64 | 0.37 | 0.20 | |
| Total assets | 777.78 | 608.48 | 341.86 | 71.14 | 109.93 | 161.62 | 83.18 | 77.74 | 56.08 | 67.06 | 38.65 | 2.93 | 4.60 |
| Total current liabilities | 58.69 | 54.06 | 31.98 | 14.66 | 20.14 | 16.44 | 18.36 | 10.24 | 5.63 | 3.97 | 2.52 | 1.06 | 1.41 |
| Total non-current liabilities | 3.86 | 36.62 | 125.87 | 6.18 | 5.84 | 5.34 | 4.74 | 0.07 | 0.11 | 0.13 | 0.03 | ||
| Total liabilities | 62.55 | 90.68 | 157.84 | 20.84 | 25.99 | 21.79 | 23.10 | 10.31 | 5.74 | 4.10 | 2.55 | 1.06 | 1.41 |
| Total stockholders' equity | 715.24 | 517.80 | 184.02 | 50.31 | 83.94 | 139.83 | 60.08 | 67.43 | 50.34 | 62.97 | 36.10 | 1.87 | 3.19 |
| Common shares outstanding | 346 | 47 | 7 | 3 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | |
Show Quarterly Balance Sheet
Balance Sheet - Spyre Therapeutics, Inc. (SYRE)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | Dec-17 | Sep-17 | Jun-17 | Mar-17 | Dec-16 | Sep-16 | Jun-16 | Mar-16 | Dec-15 | Sep-15 | Jun-15 | Mar-15 | Dec-14 | Sep-14 | Jun-14 | Mar-14 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 741.47 | 756.53 | 486.20 | 526.58 | 564.82 | 603.09 | 414.23 | 426.00 | 484.64 | 339.28 | 203.60 | 235.36 | 38.48 | 55.71 | 73.68 | 88.55 | 66.73 | 93.13 | 112.43 | 128.58 | 126.66 | 146.27 | 139.98 | 157.73 | 48.99 | 71.95 | 88.70 | 105.54 | 123.72 | 74.51 | 64.74 | 72.19 | 43.48 | 50.30 | 55.75 | 63.39 | 57.87 | 63.50 | 68.04 | 73.58 | 28.99 | 33.06 | 34.14 | 39.08 | 43.79 | 2.62 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 4.60 | 3.60 | 3.50 | 0.16 | 1.65 | 0.33 | 0.38 | 0.67 | 0.48 | 1.01 | 0.82 | 21.50 | 2.42 | 4.28 | 3.37 | 3.08 | 2.45 | 1.21 | 0.98 | 1.22 | 1.57 | 1.63 | 1.62 | 1.70 | 4.24 | 3.43 | |||||||||||||||||||||||
| Inventories | 0.00 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Other current assets | 17.89 | 21.25 | 18.41 | 12.25 | 4.95 | 5.39 | 6.85 | 9.74 | 2.63 | 2.25 | 2.19 | 2.88 | 5.57 | 6.17 | 7.87 | 7.62 | 4.86 | 4.95 | 5.09 | 5.79 | 3.25 | 3.52 | 4.42 | 4.14 | 5.27 | 2.56 | 3.93 | 4.39 | 3.10 | 2.16 | 3.23 | 2.41 | 2.00 | 1.61 | 1.32 | 1.60 | 1.46 | 1.71 | 2.07 | 1.71 | 4.60 | 3.53 | 3.35 | 2.87 | 0.30 | 0.11 | |||
| Total current assets | 763.95 | 777.78 | 504.60 | 538.83 | 569.77 | 608.47 | 421.08 | 435.74 | 487.27 | 341.53 | 205.95 | 239.89 | 44.38 | 62.26 | 82.22 | 96.65 | 72.60 | 98.89 | 117.51 | 134.37 | 151.41 | 149.79 | 144.40 | 161.87 | 54.27 | 74.51 | 92.63 | 109.94 | 126.82 | 76.67 | 70.38 | 78.89 | 48.84 | 54.99 | 59.52 | 66.20 | 60.31 | 66.42 | 71.68 | 76.91 | 35.20 | 38.29 | 41.73 | 45.38 | 44.10 | 2.73 | |||
| Total non-current assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.33 | 0.33 | 0.33 | 1.32 | 3.64 | 8.08 | 8.89 | 9.35 | 10.06 | 10.57 | 11.04 | 11.55 | 12.61 | 12.20 | 11.83 | 11.23 | 11.05 | 10.52 | 8.68 | 7.47 | 7.56 | 1.70 | 1.07 | 0.90 | 0.83 | 0.94 | 1.09 | 0.98 | 0.94 | 0.96 | 0.64 | 0.38 | 0.40 | 0.34 | 0.37 | 0.38 | 0.27 | 0.26 | 0.20 | |||
| Total assets | 763.95 | 777.78 | 504.60 | 538.83 | 569.78 | 608.48 | 421.09 | 436.07 | 487.60 | 341.86 | 207.27 | 243.53 | 52.45 | 71.14 | 91.57 | 106.71 | 83.17 | 109.93 | 129.06 | 146.98 | 163.61 | 161.62 | 155.63 | 172.91 | 64.78 | 83.18 | 100.10 | 117.49 | 128.52 | 77.74 | 71.28 | 79.71 | 49.79 | 56.08 | 60.50 | 67.14 | 61.27 | 67.06 | 72.06 | 77.30 | 35.54 | 38.65 | 42.10 | 45.64 | 44.35 | 2.93 | |||
| Total current liabilities | 85.16 | 58.69 | 46.27 | 83.06 | 70.68 | 54.06 | 57.54 | 22.12 | 42.82 | 31.98 | 44.87 | 232.23 | 12.64 | 14.66 | 17.68 | 15.86 | 16.30 | 20.14 | 20.43 | 20.60 | 32.37 | 16.44 | 14.35 | 15.89 | 17.14 | 18.36 | 15.40 | 13.02 | 11.81 | 10.24 | 7.52 | 6.18 | 5.77 | 5.63 | 4.88 | 4.42 | 3.96 | 3.97 | 3.84 | 3.36 | 3.82 | 2.52 | 2.42 | 2.70 | 1.19 | 1.06 | |||
| Total non-current liabilities | 7.98 | 3.86 | 3.23 | 0.00 | 16.49 | 36.62 | 36.16 | 39.56 | 292.52 | 125.87 | 407.80 | 218.66 | 6.16 | 6.18 | 6.33 | 6.69 | 5.22 | 5.84 | 6.55 | 7.35 | 7.49 | 5.34 | 5.01 | 4.76 | 4.84 | 4.74 | 4.91 | 4.86 | 0.42 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.12 | 0.13 | 0.13 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | ||||
| Total liabilities | 93.14 | 62.55 | 49.50 | 83.06 | 87.17 | 90.68 | 93.70 | 61.68 | 335.33 | 157.84 | 452.67 | 450.90 | 18.80 | 20.84 | 24.01 | 22.55 | 21.51 | 25.99 | 26.98 | 27.96 | 39.86 | 21.79 | 19.36 | 20.65 | 21.98 | 23.10 | 20.30 | 17.88 | 12.23 | 10.31 | 7.60 | 6.27 | 5.87 | 5.74 | 4.99 | 4.54 | 4.08 | 4.10 | 3.86 | 3.38 | 3.84 | 2.55 | 2.45 | 2.74 | 1.23 | 1.06 | |||
| Total stockholders' equity | 670.81 | 715.24 | 455.10 | 455.77 | 482.61 | 517.80 | 327.39 | 374.39 | 152.27 | 184.02 | -245.40 | -207.37 | 33.65 | 50.31 | 67.56 | 84.16 | 61.66 | 83.94 | 102.08 | 119.02 | 123.76 | 139.83 | 136.27 | 152.26 | 42.81 | 60.08 | 79.80 | 99.62 | 116.29 | 67.43 | 63.68 | 73.45 | 43.92 | 50.34 | 55.51 | 62.60 | 57.18 | 62.97 | 68.20 | 73.92 | 31.70 | 36.10 | 39.65 | 42.90 | 43.12 | 1.87 | |||
| Common shares outstanding | 346 | 346 | 60 | 61 | 60 | 47 | 51 | 45 | 37 | 22 | 4 | 4 | 4 | 3 | 4 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |